Editorial Policies

Aims and Scope

The mission of the Journal is to present current achievements of medical science and practice, and to help doctors in mastering progressive methods of diagnosis and treatment of a wide range of diseases.

The main scope of the journal is around wollow fields:  

Clinical Medicine

Obstetrics & Gynecology
ENT diseases
Internal medicine
Cardiology
Eye diseases
Paediatrics
Infectious diseases
Diseases of the nervous system
Oncology
Dentistry
Traumatology and orthopaedics
Phthisiology
Surgery
Pulmonology
Gastroenterology
Gerontology and geriatrics

Preventive Medicine

Hygiene
Public health and health service
Occupational medicine

Medical and biological sciences

Human anatomy

Sections

Original Studies

The journal accept manuscript containing results of international and local clinical and experimental studies, and meta-analyzes.

The journal is welcome for manuscripts with human subjects studies results, as well as results of experimental studies in vitro and animal studies.

Editorial board will select for publication only manuscropts of clinical and experimental studies which were conducted in accordance with international biomedical ethics and deontology principles. Editorial board asks the authors to describe that presented study was conducted in accordance with international GCP standards: voluntary signing of an informed consent by all of participants; approval of the study protocol by the local ethics committee (the distinct name of ethics committee, the meeting date and protocol number should be indicate in a manuscript), etc.

The detailed study protocol should be presented in the manuscript. Authors should give so many details of a study protocol as need for it fully replaying. In the case of meta-analyze authors should describe in details the procedure of information search: names of databases, filters and keywords, as well as any additional search settings for primary sources collecting.

In compliance with the ethics policy editorial board asks authors to indicate the source of funding of their work (study preparation, writing and publishing the manuscript, etc.), and declare of apparent or potential conflicts of interests. Please note that the presence of obvious or potential conflict of interest (including the financial interest of the authors) or affiliation of any organization (public or private) with conduction of the research is not a reason for a manuscript rejection. Rather, it gives additional advantages of manuscript under evaluation by reviewers and will cause more interest and trust from readers.

Open Submissions

Indexed

Peer Reviewed

Review

The journal publishes science reviews, including systematic reviews of clinical trials in different directions of medicine.

The main purpose of a review manuscript should be a discussion of actual data or presentation the original author's view on a problem. It shouldn't be a simple enumeration of previously published data. Thus, the discussion is a mandatory part of the review manuscript (it can be isolated in a separate section or place systematically throughout the text).

Authors should indicate all the sources of primary information in the manuscript (names of the full-text and references databases, keywords and other search settings).

The manuscript of literature review should be structured into sections and contain graphic materials.

Open Submissions

Indexed

Peer Reviewed

Short Messages

The journal is looking for manuscripts with case reports in the area of clinical and experimental medicine.

Potential topics for case reports are:

• diagnosis - new or rare diabetes-related condition or unusual presentation of common condition, uncertain diagnosis situation, discussion of differential diagnoses, novel diagnostic procedures;
• treatment - new treatments or established treatments in new situations, treatment of rare diabetes-related conditions, unique technical procedures, unexpected outcomes or effects from routine or rare procedures, adverse events or unanticipated events;
• special circumstances - highly individualized treatments, complex situations, integration of multiple therapies, ethical challenges, learning from errors, findings that shed new light on the possible pathogenesis of a disease or an adverse effect.

The main purpose of a manuscript should be a clinical case presentation in view of diagnostic approach, ethical or management challenge, or highlights new aspects of pathogenesis, pharmacology or histopathology. Manuscript should discuss accumulated facts and also compare new data with previously proven information.

We recommend all authors to hold the manuscript structure and chronologize all the facts, report common information about the patient’s disease. In case your manuscript is devoted to treatment challenge, describe the medication, its indications and usage specifications also with any potential side effects. A summary of data on the topic may be also presented. Briefly summarize the background of this case report. Describe the patient characteristics (such as the relevant demographics — age, gender, ethnicity, occupation) and their presenting concerns with relevant details of related past interventions. Also, present the medical, family, and psychosocial history including lifestyle and genetic information, other pertinent co-morbidities and interventions (other therapies including self-care).

Data structure for a case report should include the following sections:

• symptoms of the disorder;
• physical examination focused on the important findings including results from testing;
• diagnostic methods (including laboratory testing, imaging results, questionnaires, referral diagnostic information);
• diagnostic challenges (such as limited ability to complete an evaluation, patient availability, cultural) and diagnostic reasoning including other diagnoses considered;
• interventions (such as pharmacologic, surgical, preventive, lifestyle, self-care);
• administration and intensity of the intervention (including dosage, strength, duration, frequency);
• prognostic characteristics.

Please describe the strengths and limitations of this case report including case management, and the scientific and medical literature related to this case report. Discuss the rationale for your conclusions such as potential causation and the ways this case might be generalized to a larger population. Finally, what are the main findings of this case report and what are the 'take-away' messages?

Open Submissions

Indexed

Peer Reviewed

Otorhinolaryngology

Open Submissions

Indexed

Peer Reviewed

Microbiology

Open Submissions

Indexed

Peer Reviewed

Peer Review Process

A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of “Science and Innovations in Medicine”. This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer.

1. Members of the editorial board and leading Russian and international experts in corresponding areas of life sciences, invited as independent readers, perform peer reviews. Editor-in-chief, deputy editor-in-chief or science editor choose readers for peer review. We aim to limit the review process to 2-4 weeks, though in some cases the schedule may be adjusted at the reviewer’s request.
2. Reviewer has an option to abnegate the assessment should any conflict of interests arise that may affect perception or interpretation of the manuscript. Upon the scrutiny, the reviewer is expected to present the editorial board with one of the following recommendations: to accept the paper in its present state; to invited the author to revise their manuscript to address specific concerns before final decision is reached; that final decision be reached following further reviewing by another specialist; to reject the manuscript outright.
3. If the reviewer has recommended any refinements, the editorial staff would suggest the author either to implement the corrections, or to dispute them reasonably. Authors are kindly required to limit their revision to 2 months and resubmit the adapted manuscript within this period for final evaluation.
4. We politely request that the editor be notified verbally or in writing should the author decide to refuse from publishing the manuscript. In case the author fails to do so within 3 months since receiving a copy of the initial review, the editorial board takes the manuscript off the register and notifies the author accordingly.
5. If author and reviewers meet insoluble contradictions regarding revision of the manuscript, the editor-in-chief resolves the conflict by his own authority.
6. The editorial board reaches final decision to reject a manuscript on the hearing according to reviewers’ recommendations, and duly notifies the authors of their decision via e-mail. The board does not accept previously rejected manuscripts for re-evaluation.
7. Upon the decision to accept the manuscript for publishing, the editorial staff notifies the authors of the scheduled date of publication.
8. Kindly note that positive review does not guarantee the acceptance, as final decision in all cases lies with the editorial board. By his authority, editor-in-chief rules final solution of every conflict.
9. Original reviews of submitted manuscripts remain deposited permanently (not less than 5 years).
10. Reviews can be sent to the Ministry of Education and Sciense of Russian Federation in case of query.

Publication Frequency

The journal publish 4 issues per year (quarterly).

Open Access Policy

The publications in the Journal are available to all interested from the moment of publication. So, this journal provides immediate Gold Open Access (in accordance with Budapest Open Access Initiative) to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Also the editorial board belives that it provides free public access to the results of research and contributes to the advancement of science and medicine.

Free Full-text access to all articles can be observed via several websites (www.journals.eco-vector.com/2500-1388/, www.elibrary.ru, http://www.innoscience.ru/en/) and mobile applications for iOS® (available in AppStore). All accepted articles publish with the Creative Commons International license (CC BY) for more freely distribution and usage worlwide.

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.

Indexation

The Science and Innovations in Medicine Journal is included into the “List of leading scientific journals under review, where principal data of applicants for scientific degree has to be published”, as decreed by State Commission for Academic Degrees and Titles and revised in 2019.

The journal is indexed in the following international databases and directory editions:

• Russian Science Citation Index - is a database, accumulating information on papers by Russian scientists, published in native and foreign titles. The SCIENCE INDEX project is under development since 2005 by “Electronic Scientific Library” foundation (elibrary.ru).
• Google Scholar
• Ulrich's Periodical Directory
• WorldCat
• Crossref

Publication Ethics

EDITORIAL RESPONSIBILITY

Editorial board of the journal "Science and Innovations in Medicine" adhere to the ethical norms approved by international scientific society. The following documents are recognized as defining ethical policy of the journal:

1) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals by International Committee of Medical Journal Editors (ICMJE);

2) Recommendations of the Committee on Publication ethics (COPE).

EDITORIAL DECISION

Editorial team makes a decision which of the articles submitted to the journal should be published. The decision for publication of each article is basedupon its scientific relevance, authenticity, clarity of presentation and compliance of the research topic with the scientific direction of the journal.

Dealing with the question of paper acceptance, the editorial boardis guided by the policy of the journal taking into account the existing copyright legislation, avoiding cases of libel and plagiarism. Editorial assessment of the manuscript is conducted regardless of race, ethnic background, gender, religious beliefs, nationality or political philosophy of the authors.

CONFIDENTIALITY

The editorial staff has personal responsibility for the disclosure of any information about a submitted manuscript to anyone other than the corresponding authors, reviewers, potential reviewers and publishers.

CONFLICT OF INTEREST

The editorial staff must not use the unpublished materialpresented in authors' manuscripts in their own research without the written consent of the authors.

ANTI-PLAGIARISM

Plagiarism is a serious violation of Editorial Ethics.

Manuscripts submitted to the journal "Science and Innovations in Medicine" are tested for plagiarism using "ANTIPLAGIAT" system. Identifying plagiarism is a part of scientific review. In case of unauthorized borrowings and low coefficient of text originality, the editors make a decision to reject the paper.

Furthermore, the editorial boardmay receive written notifications of plagiarism from different sources — readers, professional and social organizations, government structures and establishments. According to the international standards, on receiving such a message, the editorial board must send a letter of response with information about the initiation of editorial investigation and its time frame (1—2 months).

The editorial board is obliged to consider any claim for the facts of unethical behavior, even if it is received years after the article publication.

After finishing the investigation, the editorial staff must inform the person or organizationreportingabout the fact of plagiarism about the decision and actions taken.

In case ofminor plagiarism, the editorial board informs the author about the revealedfact ofplagiarism and receives written explanations.

If the author’s violation is qualified as unintentional,the editor only makes a comment and notifies about the impermissibility of repeated violation.

If the violation is qualified as deliberate or repeated, the editorial boardpublishes updating report in the next issue of the journal. The updating report includes the fullreference to the previously published paper and citation of all the borrowed fragments with the references to the original sources.

In case ofsignificant plagiarism,the editorial boardinitiates the process of retraction of the author’s article.

The retraction results are presented in both print and electronic versions of the journal.

The editors must report about the fact of retraction to allthe databases in which the journal is indexed.

The editors observe regularly updated informationon international retractions via the blog http://retractionwatch.com.

COMPLIANCE WITH STANDARDS OF BIOMEDICAL ETHICS

The journal publishes only the results of the researchesconducted according to thestandards of biomedical ethics.

The manuscripts should indicate all the risks (manifested and potential) that were posed to the objects of study (people or animals).

RESPONSIBILITIES OF REVIEWERS

PARTICIPATION IN MAKING EDITORIAL DECISIONS

Reviewing procedure supports the editors in making editorial decisions and alsocan help the authors to improve the submitted manuscript.

PROMPTNESS OF REVIEWING

If the reviewer selected by the editor does not have sufficient qualifications for reviewing the manuscript or realizes that he/she does not have the opportunity to produce a review within the time limits specified by the editorial board, he/she must immediately notify the editorial office and withdraw from further review process.

CONFIDENTIALITY

Any material received for review must be treated as a confidential document. The submitted materials must not be shown to or discussed with other people without prior consent of the editorial board.

STANDARDS OF OBJECTIVITY

Reviews should be conducted objectively. Personal criticism of the author is unacceptable. Reviewer’s opinionshould be expressed clearly, with supporting points.

ACKNOWLEDGEMENT OF SOURCES

Reviewers should identifythe cases when relevant published works were not citedin the manuscript or were not indicated in the reference list. In addition, the reviewermonitors if all the statements,conclusions and ideas that were borrowed from other papers are accompanied by correspondingsource reference. If the reviewer noticesany substantial similarity between the manus­cript under consideration and any other known published paper, he/she is obliged to inform the editorial board about this fact.

INFORMATION DISCLOSURE AND CONFLICT OF INTEREST

Undisclosable information and ideas that the reviewer receives during the review of the manuscript are considered confidential, and therefore cannot be used by the reviewer for personal purposes. The reviewer has no right to review the manuscripts in respect of which he/she has a conflict of interests due to competitive, collegial or any other connections with the authors of the manuscript, as well as companies or institutions related to the manuscript.

RESPONSIBILITY OF AUTHORS

RELIABILITY AND STANDARDS OF RESEARCH

If the article is based on an original study, the authors must provide reliable results of the conducted work and an objective discussion of the significance of the research. The manuscript should contain all the key data, as well as accurate description of the details of the study and links to ensure the reproducibility of the results. Falsification of data or knowingly incorrect statements in the manuscript are considered unethical and unacceptable.

ACCESSIBILITY OF DATA

In addition to the manuscript, the editors have the right to request original data from the authors. The author is obliged to allow access to it (provided that this access will not violate the confidentiality of the participants of the experiment, as well as the personal or corporate rights of the dataowners).

ORIGINALITY, PLAGIARISM AND REFERENCES

Authors mustsubmit only original works. Referring to the works of other authors, the author must observe accuracy in citing and indicating the source. Publications that have significantly influenced the preparation of the research or defined its format should also be mentioned in the article.

MULTIPLE, REPEATED OR CONCURRENT PUBLICATIONS

Materials describing the content of the same research should not be published in more than one journal. Sending a manuscript to more than one journalis considered unethical and unacceptable.

Copyrighted materials that have already been publishedcannot be submitted for publication. Likewise, submitted materials under consideration cannot be sent to another journal for publication as a copyrighted article.

When submitting an article, the author should inform the editor about all previous submissions of the paper, which can be considered as duplicating or double publication.

The author is obliged to warn the editor that the manuscript contains information published in previous reports or submitted for another publication.

In these cases, the new article should contain references to the preceding material.

AUTHORSHIP CRITERIA

The list of authors should include only those who have made a significant contribution into

• concept and design of the research, acquisition and interpretation of the data;
• drafting the work or its critical revision aimed at improving the quality;
• final approval of the version to be published.

The contribution of each author should besufficient to take public responsibility for the corresponding part of the content of the article.

Participation in providing funding or selecting material for the article is not sufficient for authorship.

The overall management of the research team is not recognized as sufficient for authorship either.

All persons indicated as authors must approve the final version of the manuscript, as well as its submission to the journal for publication.

CONFLICT OF INTEREST

When submitting a manuscript to the journal, all the authors sign a Form for Disclosure of Conflicts of Interest concerning any existing financial or other significant conflicts of interest that may be regarded as having affected the results of the study or their interpretation. Furthermore, all sources of funding for the described work should be specified.

COMPLIANCE WITH STANDARDS OF BIOMEDICAL ETHICS

If the experimental research included people or animals as the objects of study, the authors are obliged to report in the manuscript that all stages of the research were conducted in accordance with the legislation and regulatory documents. The manuscript should reflect that voluntary informed consent was obtained from all people who were the objects of study.

PARTICIPATION IN THE REVIEW PROCESS

Based on the results of the review, the article may be sent to the author for revision. Authors should actively participate in the review process, respond promptly to questions and, if necessary, correct the manuscript in accordance with the requirements of the reviewer.

Publication Fees

Publication in Science and Innovations in Medicine journal is free for all authors.

The Science and Innovations in Medicine journal charge no publication fees for authors - including those of peer-review management, manuscript processing, journal production, Open-Access, online hosting and archiving.

---